BR9708654A - Derivatives of 3 - [(1,2,3,4-tetrahydroisoquinolein-2-yl) methyl] -8-azabici clo [3.2.1] octane its preparation and its application in therapy - Google Patents

Derivatives of 3 - [(1,2,3,4-tetrahydroisoquinolein-2-yl) methyl] -8-azabici clo [3.2.1] octane its preparation and its application in therapy

Info

Publication number
BR9708654A
BR9708654A BR9708654A BR9708654A BR9708654A BR 9708654 A BR9708654 A BR 9708654A BR 9708654 A BR9708654 A BR 9708654A BR 9708654 A BR9708654 A BR 9708654A BR 9708654 A BR9708654 A BR 9708654A
Authority
BR
Brazil
Prior art keywords
tetrahydroisoquinolein
azabici
clo
octane
therapy
Prior art date
Application number
BR9708654A
Other languages
Portuguese (pt)
Inventor
Mireille Sevrin
Benoit Marabout
Pascal George
Jean-Pierre Merly
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of BR9708654A publication Critical patent/BR9708654A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR9708654A 1996-04-12 1997-04-10 Derivatives of 3 - [(1,2,3,4-tetrahydroisoquinolein-2-yl) methyl] -8-azabici clo [3.2.1] octane its preparation and its application in therapy BR9708654A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9604565A FR2747386B1 (en) 1996-04-12 1996-04-12 DERIVATIVES OF 3 - [(1,2,3,4-TETRAHYDROISOQUINOLEIN-2-YL) METHYL] -8-AZABICYCLO [3.2.1] OCTANE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
PCT/FR1997/000634 WO1997038998A1 (en) 1996-04-12 1997-04-10 3-[(1,2,3,4-tetrahydroisoquinoline-2-yl)methyl]-8-azabicyclo[3.2.1]octane derivatives, their preparation and their application in therapeutics

Publications (1)

Publication Number Publication Date
BR9708654A true BR9708654A (en) 1999-08-03

Family

ID=9491132

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9708654A BR9708654A (en) 1996-04-12 1997-04-10 Derivatives of 3 - [(1,2,3,4-tetrahydroisoquinolein-2-yl) methyl] -8-azabici clo [3.2.1] octane its preparation and its application in therapy

Country Status (22)

Country Link
EP (1) EP0892800A1 (en)
JP (1) JP2000512620A (en)
KR (1) KR20000005392A (en)
CN (1) CN1216046A (en)
AR (1) AR008587A1 (en)
AU (1) AU2640997A (en)
BG (1) BG102779A (en)
BR (1) BR9708654A (en)
CA (1) CA2251335A1 (en)
CO (1) CO4900067A1 (en)
CZ (1) CZ326898A3 (en)
EE (1) EE9800396A (en)
FR (1) FR2747386B1 (en)
IL (1) IL126473A0 (en)
NO (1) NO984736L (en)
NZ (1) NZ332257A (en)
PL (1) PL329243A1 (en)
SK (1) SK141598A3 (en)
TR (1) TR199801839T2 (en)
TW (1) TW407158B (en)
WO (1) WO1997038998A1 (en)
ZA (1) ZA973124B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102131790A (en) * 2008-06-27 2011-07-20 H.隆德贝克有限公司 Novel phenolic and catecholic amines and prodrugs thereof
JP7015092B2 (en) 2016-07-28 2022-02-02 塩野義製薬株式会社 Nitrogen-containing fused ring compound having dopamine D3 receptor antagonistic activity
WO2019146739A1 (en) 2018-01-26 2019-08-01 塩野義製薬株式会社 Condensed cyclic compound having dopamine d3 receptor antagonism

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8701682A (en) * 1986-07-30 1988-02-16 Sandoz Ag METHOD FOR THE THERAPEUTIC USE OF SEROTONIN ANTAGONISTS, ACTIVE COMPOUNDS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS
EP0306375A1 (en) * 1987-08-07 1989-03-08 Synthelabo 2-[(4-Piperidinyl)methyl]-1,2,3,4-tetrahydroisoquinoline derivatives, their preparation and their use in therapy
IL89156A (en) * 1988-07-12 1993-05-13 Synthelabo Derivatives of 2-((4-piperidinyl) methyl)- 1,2,3,4- tetrahydroisoquinoline, their preparation and their application in therapeutics
FR2661178B1 (en) * 1990-04-24 1993-03-12 Synthelabo DERIVATIVES OF [(TETRAHYDRO-1,2,3,4 ISOQUINOLEINYL-2) METHYL] -4 PIPERIDINECARBOXYLATES-1 OF ALKYL, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION.

Also Published As

Publication number Publication date
PL329243A1 (en) 1999-03-15
ZA973124B (en) 1997-11-05
NO984736D0 (en) 1998-10-09
FR2747386B1 (en) 1998-05-15
EE9800396A (en) 1999-06-15
SK141598A3 (en) 1999-03-12
JP2000512620A (en) 2000-09-26
CN1216046A (en) 1999-05-05
EP0892800A1 (en) 1999-01-27
TR199801839T2 (en) 1998-12-21
CA2251335A1 (en) 1997-10-23
CZ326898A3 (en) 1999-01-13
IL126473A0 (en) 1999-08-17
WO1997038998A1 (en) 1997-10-23
NO984736L (en) 1998-11-23
AR008587A1 (en) 2000-02-09
CO4900067A1 (en) 2000-03-27
BG102779A (en) 1999-09-30
AU2640997A (en) 1997-11-07
TW407158B (en) 2000-10-01
FR2747386A1 (en) 1997-10-17
NZ332257A (en) 1999-03-29
KR20000005392A (en) 2000-01-25

Similar Documents

Publication Publication Date Title
PT869126E (en) DITIOLAN DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC EFFECTS
PT880533E (en) U.S. TRIAZOLE DERIVATIVES IN THERAPY
ZA966075B (en) Protein formulation.
NL300295I1 (en) 3,3-Diarylpropylamines, their use and preparation
HUP9801910A3 (en) Dolastatin derivatives, their preparation and use
AU6514196A (en) Heterocyclic compounds, their preparation and use
FR2786769B1 (en) 2,5-DIAZABICYCLO [2.2.1] HEPTANE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
PL344346A1 (en) Platinum complex, its preparation and therapeutic application
AU9633098A (en) Benzoxazine derivatives, preparation and application in therapy
AU6514296A (en) Heterocyclic compounds, their preparation and use
ZA963485B (en) Azacycloalkane derivatives, their preparation and their application in therapy
HUP9904206A3 (en) 1,4-diazabicyclo[2.2.2.]oct-2-ylmethyl derivatives,their preparation and therapeutic application
BR9611179A (en) Cream composition
AU5591296A (en) N-((1,4-diazabicyclo(2.2.2)oct-2-yl)methyl)benzamide derivatives, their preparation and their application in therapeutics
ZA989664B (en) 3-substituted tetrahydropyrimidinone derivatives, their preparation and use.
HUP0201762A2 (en) Platinum complex, its preparation and therapeutic application
ZA978772B (en) N-(2-benzothiazolyl)-1-piperidineethanamine derivatives, their preparation and their use in therapy.
BR9708654A (en) Derivatives of 3 - [(1,2,3,4-tetrahydroisoquinolein-2-yl) methyl] -8-azabici clo [3.2.1] octane its preparation and its application in therapy
IL135520A0 (en) 8-azabicyclo [3.2.1.] octane-3-methanamine derivatives, their preparation and their therapeutic application
ZA966616B (en) Benzenesulphonamide derivatives, their preparation and their application in theraphy.
BR9611178A (en) Cream composition
IL133536A0 (en) 6-pyrrolidin-2-ylpyridine derivatives, their preparation and application in therapy
IT1281757B1 (en) MIXER, IN PARTICULAR FOR BUILDING
EP0586154A3 (en) Melanin formation-inhibitory protein, and its preparation and uses.
AU3153199A (en) Azacycloalkane derivatives, preparation and therapeutic application

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]